DoW Arthritis Clinical Research Award

The summary for the DoW Arthritis Clinical Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept. of the Army -- USAMRAA, which is the U.S. government agency offering this grant.
DoW Arthritis Clinical Research Award: Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Clinical Research Award (CRA) supports clinical research that evaluates disease-specific factors and interventions. Research is intended to generate clinically useful evidence with potential to optimize patient outcomes and inform clinical care or policy. Research addressing any and all types of arthritis is encouraged.Applications must address one of two FY26 ATRP CRA Focus Areas: Prevention and Early Diagnosis, or Treatment and Mitigation of Disease Progression/Burden.Distinctive Features: The FY26 ATRP CRA offers funding for two research levels. It is the responsibility of the applicant to select the level that aligns with the scope of the proposed research.• Research Level 1: Applications proposing clinical research or early-phase/pilot clinical trials, to include new or emerging research that is not ready for a full-scale randomized controlled clinical trial.• Research Level 2: Applications proposing a full-scale clinical trial.Applications should include a community collaborator (e.g., patient/care partner, community-based organization consultant) who will provide advice and consultation during study design and throughout study planning and implementation. The ATRP encourages a community collaborator for Research Level 1 applications and requires a community collaborator for Research Level 2 applications.Preliminary and/or published data are required.
Federal Grant Title: DoW Arthritis Clinical Research Award
Federal Agency Name: Dept. of the Army -- USAMRAA (DOD-AMRAA)
Grant Categories: Science and Technology and other Research and Development
Type of Opportunity: Discretionary
Funding Opportunity Number: HT942526ATRPCRA
Type of Funding: Grant
CFDA Numbers: 12.420
CFDA Descriptions: Information not provided
Current Application Deadline: October 22nd, 2026
Original Application Deadline: October 22nd, 2026
Posted Date: May 1st, 2026
Creation Date: May 1st, 2026
Archive Date: November 21st, 2026
Total Program Funding: $7,150,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 4
Cost Sharing or Matching: No
Last Updated: May 1st, 2026
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
eBRAP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk
Similar Government Grants
• DoW Breast Cancer, Breakthrough Award Levels 1 and 2
• DoW Breast Cancer, Clinical Research Extension Award
• DoW Reconstructive Transplant, Investigator-Initiated Research Award
• DoW Neurofibromatosis Exploration-Hypothesis Development Award
• DoW Neurofibromatosis Research Academy - Scholar Award
• FY2006 Deployed War Fighter Protection Research Program
• Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
• Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Dept. of the Army -- USAMRAA
• DoW Bone Marrow Failure, Resource Development Award
• DoW Joint Warfighter Medical, Military Medical Research and Development Award
• DoW Rare Cancers Resource and Community Development Award
• DoW Duchenne Muscular Dystrophy Clinical/Translational Award
• DoW Duchenne Muscular Dystrophy, Idea Development Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com